Compounds derived from [1,2,3] triazolo [4,5-d] - pyrimidine receptor agonists of cannabinoid 2； extraction process； Pharmaceutical Composition and use for the Treatment or prophylaxis of Pain, Diabetic Retinopathy, atherosclerosis, diabetes, hepatic fibrosis, Heart Failure, among others.

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

GRETHER UWE,KIMBARA ATSUSHI,NETTEKOVEN MATTHIAS,ROEVER STEPHAN,ROGERS -EVANS AMRK,BISSANTZ CATERINA

申请号：

CL2014001309

公开号：

CL2014001309A1

申请日:

2014.05.19

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The invention relates to a compound of formula (I) wherein A and R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.COMPUESTOS DERIVADOS DE [1,2,3] TRIAZOLO [4,5-D]-PIRIMIDINA, AGONISTAS DEL RECEPTOR DE CANABINOIDES 2； PROCESO DE OBTENCION； COMPOSICION FARMACEUTICA； USO PARA EL TRATAMIENTO O LA PROFILAXIS DEL DOLOR, ATEROSCLEROSIS, RETINOPATIA DIABETICA, DIABETES, FIBROSIS HEPATICA, FALLO CARDIACO, ENTRE OTRAS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/